MIDDLE TENNESSEE STATE UNIV has a total of 22 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2015. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are SRX CARDIO LLC, NYCOMED DAK AS and REXAHN PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | EPO (European Patent Office) | 5 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Measurement | |
#5 | Environmental technology | |
#6 | Foods and drinks |
# | Name | Total Patents |
---|---|---|
#1 | Altman Elliot | 12 |
#2 | Park Hyo | 10 |
#3 | Gao Ying | 8 |
#4 | Farone Anthony | 7 |
#5 | Handy Scott | 6 |
#6 | Taylor Zachary E | 6 |
#7 | Stubblefield Jeannie | 5 |
#8 | Newsome Anthony | 4 |
#9 | Mcclelland Erin | 3 |
#10 | Farone Mary | 3 |
Publication | Filing date | Title |
---|---|---|
WO2020223439A1 | Aurones and methods of using aurones to treat tuberculosis | |
US2020188354A1 | Antifungal peptoids | |
US2020080955A1 | Electrochemical sensing nanocomposite | |
WO2017189891A1 | Methods for treating zika viral infections and associated complications | |
EP3442520A1 | Therapeutic aurones | |
WO2017165306A1 | ASSAY FOR HIGH-THROUGHPUT lDENTIFICATION OF THERAPEUTIC COMPOUNDS | |
EP3328405A1 | Cis-and trans-suffruticosol d as therapeutic agents | |
WO2017004215A1 | Anti-trypanosomal compounds and methods | |
WO2016106342A2 | Methods for treating immune-mediated viral infections | |
US2017360722A1 | 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione as a cancer therapeutic | |
EP3197470A1 | Cis-gnetin h and trans-gnetin h as therapeutic agents |